The stock began trading at a slight premium, indicating consistent but modest investor demand. The listing, according to analysts, roughly matched the expectations of the grey market, where the GMP has been favorable but not aggressive over the past few trading sessions.
The IPO’s steady listing suggests balanced valuation and measured investor confidence during erratic market conditions, even though it didn’t see a spectacular climb.